APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metoclopramide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Metoclopramide Market Analysis and Forecast 2026-2032

19 December 2025214 pages

Choose your research edition.

Industry ResearchMetoclopramide Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Metoclopramide Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Metoclopramide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metoclopramide Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Metoclopramide Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Metoclopramide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Metoclopramide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Metoclopramide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Metoclopramide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Metoclopramide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Metoclopramide include Adwya, Alkaloid Pharmaceuticals, Amneal Pharmaceuticals, Apotex, ASKA Seiyaku Asuka, Astellas, Biofarma, Ceva Sante Animale and EU-Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Metoclopramide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Metoclopramide, also provides the sales of main regions and countries. Of the upcoming market potential for Metoclopramide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metoclopramide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Metoclopramide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Metoclopramide sales, projected growth trends, production technology, application and end-user industry.

Metoclopramide Segment by Company

Adwya

Alkaloid Pharmaceuticals

Amneal Pharmaceuticals

Apotex

ASKA Seiyaku Asuka

Astellas

Biofarma

Ceva Sante Animale

EU-Pharma

Le Vet

Meda Pharma

Nidda

Omega Laboratories

Orion Pharma

Teuto Brasileiro

Wockhardt

Yang Sheng

GSK

Pfizer

Mylan

Novartis

Johnson and Johnson

Sanofi

Teva

Metoclopramide Segment by Type

Oral

Injection

Metoclopramide Segment by Application

Nausea

Migraine

Gastroparesis

Metoclopramide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metoclopramide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metoclopramide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metoclopramide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Metoclopramide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Metoclopramide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metoclopramide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Metoclopramide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Metoclopramide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Nausea Major Manufacturers Table 6. Migraine Major Manufacturers Table 7. Gastroparesis Major Manufacturers Table 8. Metoclopramide Industry Trends Table 9. Metoclopramide Industry Drivers Table 10. Metoclopramide Industry Opportunities and Challenges Table 11. Metoclopramide Industry Restraints Table 12. Global Metoclopramide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Metoclopramide Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Metoclopramide Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Metoclopramide Revenue Market Share by Region (2021-2026) Table 16. Global Metoclopramide Revenue Market Share by Region (2027-2032) Table 17. Global Metoclopramide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Metoclopramide Sales by Region (2021-2026) & (K Units) Table 19. Global Metoclopramide Sales by Region (2027-2032) & (K Units) Table 20. Global Metoclopramide Sales Market Share by Region (2021-2026) Table 21. Global Metoclopramide Sales Market Share by Region (2027-2032) Table 22. Global Metoclopramide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Metoclopramide Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Metoclopramide Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Metoclopramide Sales Market Share by Manufacturers (2021-2026) Table 26. Global Metoclopramide Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Metoclopramide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Metoclopramide Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Metoclopramide Manufacturers, Product Type & Application Table 30. Global Metoclopramide Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Metoclopramide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Metoclopramide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Metoclopramide Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Metoclopramide Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Metoclopramide Revenue Market Share by Type (2021-2026) Table 37. Global Metoclopramide Revenue Market Share by Type (2027-2032) Table 38. Global Metoclopramide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Metoclopramide Sales by Type (2021-2026) & (K Units) Table 40. Global Metoclopramide Sales by Type (2027-2032) & (K Units) Table 41. Global Metoclopramide Sales Market Share by Type (2021-2026) Table 42. Global Metoclopramide Sales Market Share by Type (2027-2032) Table 43. Global Metoclopramide Price by Type (2021-2026) & (US$/Unit) Table 44. Global Metoclopramide Price by Type (2027-2032) & (US$/Unit) Table 45. Global Metoclopramide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Metoclopramide Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Metoclopramide Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Metoclopramide Revenue Market Share by Application (2021-2026) Table 49. Global Metoclopramide Revenue Market Share by Application (2027-2032) Table 50. Global Metoclopramide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Metoclopramide Sales by Application (2021-2026) & (K Units) Table 52. Global Metoclopramide Sales by Application (2027-2032) & (K Units) Table 53. Global Metoclopramide Sales Market Share by Application (2021-2026) Table 54. Global Metoclopramide Sales Market Share by Application (2027-2032) Table 55. Global Metoclopramide Price by Application (2021-2026) & (US$/Unit) Table 56. Global Metoclopramide Price by Application (2027-2032) & (US$/Unit) Table 57. Adwya Company Information Table 58. Adwya Business Overview Table 59. Adwya Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Adwya Metoclopramide Product Portfolio Table 61. Adwya Recent Development Table 62. Alkaloid Pharmaceuticals Company Information Table 63. Alkaloid Pharmaceuticals Business Overview Table 64. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Alkaloid Pharmaceuticals Metoclopramide Product Portfolio Table 66. Alkaloid Pharmaceuticals Recent Development Table 67. Amneal Pharmaceuticals Company Information Table 68. Amneal Pharmaceuticals Business Overview Table 69. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Amneal Pharmaceuticals Metoclopramide Product Portfolio Table 71. Amneal Pharmaceuticals Recent Development Table 72. Apotex Company Information Table 73. Apotex Business Overview Table 74. Apotex Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Apotex Metoclopramide Product Portfolio Table 76. Apotex Recent Development Table 77. ASKA Seiyaku Asuka Company Information Table 78. ASKA Seiyaku Asuka Business Overview Table 79. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. ASKA Seiyaku Asuka Metoclopramide Product Portfolio Table 81. ASKA Seiyaku Asuka Recent Development Table 82. Astellas Company Information Table 83. Astellas Business Overview Table 84. Astellas Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Astellas Metoclopramide Product Portfolio Table 86. Astellas Recent Development Table 87. Biofarma Company Information Table 88. Biofarma Business Overview Table 89. Biofarma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Biofarma Metoclopramide Product Portfolio Table 91. Biofarma Recent Development Table 92. Ceva Sante Animale Company Information Table 93. Ceva Sante Animale Business Overview Table 94. Ceva Sante Animale Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Ceva Sante Animale Metoclopramide Product Portfolio Table 96. Ceva Sante Animale Recent Development Table 97. EU-Pharma Company Information Table 98. EU-Pharma Business Overview Table 99. EU-Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. EU-Pharma Metoclopramide Product Portfolio Table 101. EU-Pharma Recent Development Table 102. Le Vet Company Information Table 103. Le Vet Business Overview Table 104. Le Vet Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Le Vet Metoclopramide Product Portfolio Table 106. Le Vet Recent Development Table 107. Meda Pharma Company Information Table 108. Meda Pharma Business Overview Table 109. Meda Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Meda Pharma Metoclopramide Product Portfolio Table 111. Meda Pharma Recent Development Table 112. Nidda Company Information Table 113. Nidda Business Overview Table 114. Nidda Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Nidda Metoclopramide Product Portfolio Table 116. Nidda Recent Development Table 117. Omega Laboratories Company Information Table 118. Omega Laboratories Business Overview Table 119. Omega Laboratories Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Omega Laboratories Metoclopramide Product Portfolio Table 121. Omega Laboratories Recent Development Table 122. Orion Pharma Company Information Table 123. Orion Pharma Business Overview Table 124. Orion Pharma Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Orion Pharma Metoclopramide Product Portfolio Table 126. Orion Pharma Recent Development Table 127. Teuto Brasileiro Company Information Table 128. Teuto Brasileiro Business Overview Table 129. Teuto Brasileiro Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Teuto Brasileiro Metoclopramide Product Portfolio Table 131. Teuto Brasileiro Recent Development Table 132. Wockhardt Company Information Table 133. Wockhardt Business Overview Table 134. Wockhardt Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Wockhardt Metoclopramide Product Portfolio Table 136. Wockhardt Recent Development Table 137. Yang Sheng Company Information Table 138. Yang Sheng Business Overview Table 139. Yang Sheng Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Yang Sheng Metoclopramide Product Portfolio Table 141. Yang Sheng Recent Development Table 142. GSK Company Information Table 143. GSK Business Overview Table 144. GSK Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. GSK Metoclopramide Product Portfolio Table 146. GSK Recent Development Table 147. Pfizer Company Information Table 148. Pfizer Business Overview Table 149. Pfizer Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Pfizer Metoclopramide Product Portfolio Table 151. Pfizer Recent Development Table 152. Mylan Company Information Table 153. Mylan Business Overview Table 154. Mylan Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Mylan Metoclopramide Product Portfolio Table 156. Mylan Recent Development Table 157. Novartis Company Information Table 158. Novartis Business Overview Table 159. Novartis Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Novartis Metoclopramide Product Portfolio Table 161. Novartis Recent Development Table 162. Johnson and Johnson Company Information Table 163. Johnson and Johnson Business Overview Table 164. Johnson and Johnson Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Johnson and Johnson Metoclopramide Product Portfolio Table 166. Johnson and Johnson Recent Development Table 167. Sanofi Company Information Table 168. Sanofi Business Overview Table 169. Sanofi Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Sanofi Metoclopramide Product Portfolio Table 171. Sanofi Recent Development Table 172. Teva Company Information Table 173. Teva Business Overview Table 174. Teva Metoclopramide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Teva Metoclopramide Product Portfolio Table 176. Teva Recent Development Table 177. North America Metoclopramide Revenue by Type (2021-2026) & (US$ Million) Table 178. North America Metoclopramide Revenue by Type (2027-2032) & (US$ Million) Table 179. North America Metoclopramide Sales by Type (2021-2026) & (K Units) Table 180. North America Metoclopramide Sales by Type (2027-2032) & (K Units) Table 181. North America Metoclopramide Sales Price by Type (2021-2026) & (US$/Unit) Table 182. North America Metoclopramide Sales Price by Type (2027-2032) & (US$/Unit) Table 183. North America Metoclopramide Revenue by Application (2021-2026) & (US$ Million) Table 184. North America Metoclopramide Revenue by Application (2027-2032) & (US$ Million) Table 185. North America Metoclopramide Sales by Application (2021-2026) & (K Units) Table 186. North America Metoclopramide Sales by Application (2027-2032) & (K Units) Table 187. North America Metoclopramide Sales Price by Application (2021-2026) & (US$/Unit) Table 188. North America Metoclopramide Sales Price by Application (2027-2032) & (US$/Unit) Table 189. North America Metoclopramide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. North America Metoclopramide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. North America Metoclopramide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. North America Metoclopramide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. North America Metoclopramide Sales by Country (2021-2026) & (K Units) Table 194. North America Metoclopramide Sales by Country (2027-2032) & (K Units) Table 195. North America Metoclopramide Sales Price by Country (2021-2026) & (US$/Unit) Table 196. North America Metoclopramide Sales Price by Country (2027-2032) & (US$/Unit) Table 197. United States Metoclopramide Revenue (2021-2032) & (US$ Million) Table 198. Canada Metoclopramide Revenue (2021-2032) & (US$ Million) Table 199. Europe Metoclopramide Revenue by Type (2021-2026) & (US$ Million) Table 200. Europe Metoclopramide Revenue by Type (2027-2032) & (US$ Million) Table 201. Europe Metoclopramide Sales by Type (2021-2026) & (K Units) Table 202. Europe Metoclopramide Sales by Type (2027-2032) & (K Units) Table 203. Europe Metoclopramide Sales Price by Type (2021-2026) & (US$/Unit) Table 204. Europe Metoclopramide Sales Price by Type (2027-2032) & (US$/Unit) Table 205. Europe Metoclopramide Revenue by Application (2021-2026) & (US$ Million) Table 206. Europe Metoclopramide Revenue by Application (2027-2032) & (US$ Million) Table 207. Europe Metoclopramide Sales by Application (2021-2026) & (K Units) Table 208. Europe Metoclopramide Sales by Application (2027-2032) & (K Units) Table 209. Europe Metoclopramide Sales Price by Application (2021-2026) & (US$/Unit) Table 210. Europe Metoclopramide Sales Price by Application (2027-2032) & (US$/Unit) Table 211. Europe Metoclopramide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. Europe Metoclopramide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. Europe Metoclopramide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. Europe Metoclopramide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 215. Europe Metoclopramide Sales by Country (2021-2026) & (K Units) Table 216. Europe Metoclopramide Sales by Country (2027-2032) & (K Units) Table 217. Europe Metoclopramide Sales Price by Country (2021-2026) & (US$/Unit) Table 218. Europe Metoclopramide Sales Price by Country (2027-2032) & (US$/Unit) Table 219. Germany Metoclopramide Revenue (2021-2032) & (US$ Million) Table 220. France Metoclopramide Revenue (2021-2032) & (US$ Million) Table 221. U.K. Metoclopramide Revenue (2021-2032) & (US$ Million) Table 222. Italy Metoclopramide Revenue (2021-2032) & (US$ Million) Table 223. Netherlands Metoclopramide Revenue (2021-2032) & (US$ Million) Table 224. China Metoclopramide Revenue by Type (2021-2026) & (US$ Million) Table 225. China Metoclopramide Revenue by Type (2027-2032) & (US$ Million) Table 226. China Metoclopramide Sales by Type (2021-2026) & (K Units) Table 227. China Metoclopramide Sales by Type (2027-2032) & (K Units) Table 228. China Metoclopramide Sales Price by Type (2021-2026) & (US$/Unit) Table 229. China Metoclopramide Sales Price by Type (2027-2032) & (US$/Unit) Table 230. China Metoclopramide Revenue by Application (2021-2026) & (US$ Million) Table 231. China Metoclopramide Revenue by Application (2027-2032) & (US$ Million) Table 232. China Metoclopramide Sales by Application (2021-2026) & (K Units) Table 233. China Metoclopramide Sales by Application (2027-2032) & (K Units) Table 234. China Metoclopramide Sales Price by Application (2021-2026) & (US$/Unit) Table 235. China Metoclopramide Sales Price by Application (2027-2032) & (US$/Unit) Table 236. Asia Metoclopramide Revenue by Type (2021-2026) & (US$ Million) Table 237. Asia Metoclopramide Revenue by Type (2027-2032) & (US$ Million) Table 238. Asia Metoclopramide Sales by Type (2021-2026) & (K Units) Table 239. Asia Metoclopramide Sales by Type (2027-2032) & (K Units) Table 240. Asia Metoclopramide Sales Price by Type (2021-2026) & (US$/Unit) Table 241. Asia Metoclopramide Sales Price by Type (2027-2032) & (US$/Unit) Table 242. Asia Metoclopramide Revenue by Application (2021-2026) & (US$ Million) Table 243. Asia Metoclopramide Revenue by Application (2027-2032) & (US$ Million) Table 244. Asia Metoclopramide Sales by Application (2021-2026) & (K Units) Table 245. Asia Metoclopramide Sales by Application (2027-2032) & (K Units) Table 246. Asia Metoclopramide Sales Price by Application (2021-2026) & (US$/Unit) Table 247. Asia Metoclopramide Sales Price by Application (2027-2032) & (US$/Unit) Table 248. Asia Metoclopramide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. Asia Metoclopramide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 250. Asia Metoclopramide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 251. Asia Metoclopramide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 252. Asia Metoclopramide Sales by Country (2021-2026) & (K Units) Table 253. Asia Metoclopramide Sales by Country (2027-2032) & (K Units) Table 254. Asia Metoclopramide Sales Price by Country (2021-2026) & (US$/Unit) Table 255. Asia Metoclopramide Sales Price by Country (2027-2032) & (US$/Unit) Table 256. Japan Metoclopramide Revenue (2021-2032) & (US$ Million) Table 257. South Korea Metoclopramide Revenue (2021-2032) & (US$ Million) Table 258. India Metoclopramide Revenue (2021-2032) & (US$ Million) Table 259. Australia Metoclopramide Revenue (2021-2032) & (US$ Million) Table 260. China Taiwan Metoclopramide Revenue (2021-2032) & (US$ Million) Table 261. Southeast Asia Metoclopramide Revenue (2021-2032) & (US$ Million) Table 262. SAMEA Metoclopramide Revenue by Type (2021-2026) & (US$ Million) Table 263. SAMEA Metoclopramide Revenue by Type (2027-2032) & (US$ Million) Table 264. SAMEA Metoclopramide Sales by Type (2021-2026) & (K Units) Table 265. SAMEA Metoclopramide Sales by Type (2027-2032) & (K Units) Table 266. SAMEA Metoclopramide Sales Price by Type (2021-2026) & (US$/Unit) Table 267. SAMEA Metoclopramide Sales Price by Type (2027-2032) & (US$/Unit) Table 268. SAMEA Metoclopramide Revenue by Application (2021-2026) & (US$ Million) Table 269. SAMEA Metoclopramide Revenue by Application (2027-2032) & (US$ Million) Table 270. SAMEA Metoclopramide Sales by Application (2021-2026) & (K Units) Table 271. SAMEA Metoclopramide Sales by Application (2027-2032) & (K Units) Table 272. SAMEA Metoclopramide Sales Price by Application (2021-2026) & (US$/Unit) Table 273. SAMEA Metoclopramide Sales Price by Application (2027-2032) & (US$/Unit) Table 274. SAMEA Metoclopramide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 275. SAMEA Metoclopramide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 276. SAMEA Metoclopramide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 277. SAMEA Metoclopramide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 278. SAMEA Metoclopramide Sales by Country (2021-2026) & (K Units) Table 279. SAMEA Metoclopramide Sales by Country (2027-2032) & (K Units) Table 280. SAMEA Metoclopramide Sales Price by Country (2021-2026) & (US$/Unit) Table 281. SAMEA Metoclopramide Sales Price by Country (2027-2032) & (US$/Unit) Table 282. Brazil Metoclopramide Revenue (2021-2032) & (US$ Million) Table 283. Argentina Metoclopramide Revenue (2021-2032) & (US$ Million) Table 284. Chile Metoclopramide Revenue (2021-2032) & (US$ Million) Table 285. Colombia Metoclopramide Revenue (2021-2032) & (US$ Million) Table 286. Peru Metoclopramide Revenue (2021-2032) & (US$ Million) Table 287. Saudi Arabia Metoclopramide Revenue (2021-2032) & (US$ Million) Table 288. Israel Metoclopramide Revenue (2021-2032) & (US$ Million) Table 289. UAE Metoclopramide Revenue (2021-2032) & (US$ Million) Table 290. Turkey Metoclopramide Revenue (2021-2032) & (US$ Million) Table 291. Iran Metoclopramide Revenue (2021-2032) & (US$ Million) Table 292. Egypt Metoclopramide Revenue (2021-2032) & (US$ Million) Table 293. Key Raw Materials Table 294. Raw Materials Key Suppliers Table 295. Metoclopramide Distributors List Table 296. Metoclopramide Customers List Table 297. Research Programs/Design for This Report Table 298. Authors List of This Report Table 299. Secondary Sources Table 300. Primary Sources List of Figures Figure 1. Metoclopramide Image Figure 2. Global Metoclopramide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metoclopramide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global Metoclopramide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Metoclopramide Market Size Share 2021 VS 2025 VS 2032 Figure 8. Nausea Image Figure 9. Migraine Image Figure 10. Gastroparesis Image Figure 11. Global Metoclopramide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Metoclopramide Revenue (2021-2032) & (US$ Million) Figure 13. Global Metoclopramide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Metoclopramide Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Metoclopramide Revenue Market Share by Region (2021-2032) Figure 16. Global Metoclopramide Sales (2021-2032) & (K Units) Figure 17. Global Metoclopramide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Metoclopramide Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Metoclopramide Sales YoY (2021-2032) & (K Units) Figure 20. Europe Metoclopramide Sales YoY (2021-2032) & (K Units) Figure 21. China Metoclopramide Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Metoclopramide Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Metoclopramide Sales YoY (2021-2032) & (K Units) Figure 24. Global Metoclopramide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Metoclopramide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Metoclopramide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Metoclopramide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Metoclopramide Revenue Market Share by Type (2021-2032) Figure 30. Global Metoclopramide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Metoclopramide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Metoclopramide Sales Market Share by Type (2021-2032) Figure 33. Global Metoclopramide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Metoclopramide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Metoclopramide Revenue Market Share by Application (2021-2032) Figure 36. Global Metoclopramide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Metoclopramide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Metoclopramide Sales Market Share by Application (2021-2032) Figure 39. North America Metoclopramide Revenue Share by Type (2021-2032) Figure 40. North America Metoclopramide Sales Share by Type (2021-2032) Figure 41. North America Metoclopramide Revenue Share by Application (2021-2032) Figure 42. North America Metoclopramide Sales Share by Application (2021-2032) Figure 43. North America Metoclopramide Revenue Share by Country (2021-2032) Figure 44. North America Metoclopramide Sales Share by Country (2021-2032) Figure 45. Europe Metoclopramide Revenue Share by Type (2021-2032) Figure 46. Europe Metoclopramide Sales Share by Type (2021-2032) Figure 47. Europe Metoclopramide Revenue Share by Application (2021-2032) Figure 48. Europe Metoclopramide Sales Share by Application (2021-2032) Figure 49. Europe Metoclopramide Revenue Share by Country (2021-2032) Figure 50. Europe Metoclopramide Sales Share by Country (2021-2032) Figure 51. China Metoclopramide Revenue Share by Type (2021-2032) Figure 52. China Metoclopramide Sales Share by Type (2021-2032) Figure 53. China Metoclopramide Revenue Share by Application (2021-2032) Figure 54. China Metoclopramide Sales Share by Application (2021-2032) Figure 55. Asia Metoclopramide Revenue Share by Type (2021-2032) Figure 56. Asia Metoclopramide Sales Share by Type (2021-2032) Figure 57. Asia Metoclopramide Revenue Share by Application (2021-2032) Figure 58. Asia Metoclopramide Sales Share by Application (2021-2032) Figure 59. Asia Metoclopramide Revenue Share by Country (2021-2032) Figure 60. Asia Metoclopramide Sales Share by Country (2021-2032) Figure 61. SAMEA Metoclopramide Revenue Share by Type (2021-2032) Figure 62. SAMEA Metoclopramide Sales Share by Type (2021-2032) Figure 63. SAMEA Metoclopramide Revenue Share by Application (2021-2032) Figure 64. SAMEA Metoclopramide Sales Share by Application (2021-2032) Figure 65. SAMEA Metoclopramide Revenue Share by Country (2021-2032) Figure 66. SAMEA Metoclopramide Sales Share by Country (2021-2032) Figure 67. Metoclopramide Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Metoclopramide Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Nausea
  • Migraine
  • Gastroparesis
Companies covered
  • Adwya
  • Alkaloid Pharmaceuticals
  • Amneal Pharmaceuticals
  • Apotex
  • ASKA Seiyaku Asuka
  • Astellas
  • Biofarma
  • Ceva Sante Animale
  • EU-Pharma
  • Le Vet
  • Meda Pharma
  • Nidda
  • Omega Laboratories
  • Orion Pharma
  • Teuto Brasileiro
  • Wockhardt
  • Yang Sheng
  • GSK
  • Pfizer
  • Mylan
  • Novartis
  • Johnson and Johnson
  • Sanofi
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Metoclopramide Market by Type
  3. 1.2.1 Global Metoclopramide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 Metoclopramide Market by Application
  7. 1.3.1 Global Metoclopramide Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Nausea
  9. 1.3.3 Migraine
  10. 1.3.4 Gastroparesis
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Metoclopramide Market Dynamics
  1. 2.1 Metoclopramide Industry Trends
  2. 2.2 Metoclopramide Industry Drivers
  3. 2.3 Metoclopramide Industry Opportunities and Challenges
  4. 2.4 Metoclopramide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Metoclopramide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Metoclopramide Revenue by Region
  3. 3.2.1 Global Metoclopramide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Metoclopramide Revenue by Region (2021-2026)
  5. 3.2.3 Global Metoclopramide Revenue by Region (2027-2032)
  6. 3.2.4 Global Metoclopramide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Metoclopramide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Metoclopramide Sales by Region
  9. 3.4.1 Global Metoclopramide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Metoclopramide Sales by Region (2021-2026)
  11. 3.4.3 Global Metoclopramide Sales by Region (2027-2032)
  12. 3.4.4 Global Metoclopramide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Metoclopramide Revenue by Manufacturers
  2. 4.1.1 Global Metoclopramide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Metoclopramide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Metoclopramide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Metoclopramide Sales by Manufacturers
  6. 4.2.1 Global Metoclopramide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Metoclopramide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Metoclopramide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Metoclopramide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Metoclopramide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Metoclopramide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Metoclopramide Manufacturers, Product Type & Application
  13. 4.7 Global Metoclopramide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Metoclopramide Market CR5 and HHI
  16. 4.8.2 2025 Metoclopramide Tier 1, Tier 2, and Tier 3
5 Metoclopramide Market by Type
  1. 5.1 Global Metoclopramide Revenue by Type
  2. 5.1.1 Global Metoclopramide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Metoclopramide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Metoclopramide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Metoclopramide Sales by Type
  6. 5.2.1 Global Metoclopramide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Metoclopramide Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Metoclopramide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Metoclopramide Price by Type
6 Metoclopramide Market by Application
  1. 6.1 Global Metoclopramide Revenue by Application
  2. 6.1.1 Global Metoclopramide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Metoclopramide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Metoclopramide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Metoclopramide Sales by Application
  6. 6.2.1 Global Metoclopramide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Metoclopramide Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Metoclopramide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Metoclopramide Price by Application
7 Company Profiles
  1. 7.1 Adwya
  2. 7.1.1 Adwya Company Information
  3. 7.1.2 Adwya Business Overview
  4. 7.1.3 Adwya Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Adwya Metoclopramide Product Portfolio
  6. 7.1.5 Adwya Recent Developments
  7. 7.2 Alkaloid Pharmaceuticals
  8. 7.2.1 Alkaloid Pharmaceuticals Company Information
  9. 7.2.2 Alkaloid Pharmaceuticals Business Overview
  10. 7.2.3 Alkaloid Pharmaceuticals Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Alkaloid Pharmaceuticals Metoclopramide Product Portfolio
  12. 7.2.5 Alkaloid Pharmaceuticals Recent Developments
  13. 7.3 Amneal Pharmaceuticals
  14. 7.3.1 Amneal Pharmaceuticals Company Information
  15. 7.3.2 Amneal Pharmaceuticals Business Overview
  16. 7.3.3 Amneal Pharmaceuticals Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amneal Pharmaceuticals Metoclopramide Product Portfolio
  18. 7.3.5 Amneal Pharmaceuticals Recent Developments
  19. 7.4 Apotex
  20. 7.4.1 Apotex Company Information
  21. 7.4.2 Apotex Business Overview
  22. 7.4.3 Apotex Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Apotex Metoclopramide Product Portfolio
  24. 7.4.5 Apotex Recent Developments
  25. 7.5 ASKA Seiyaku Asuka
  26. 7.5.1 ASKA Seiyaku Asuka Company Information
  27. 7.5.2 ASKA Seiyaku Asuka Business Overview
  28. 7.5.3 ASKA Seiyaku Asuka Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 ASKA Seiyaku Asuka Metoclopramide Product Portfolio
  30. 7.5.5 ASKA Seiyaku Asuka Recent Developments
  31. 7.6 Astellas
  32. 7.6.1 Astellas Company Information
  33. 7.6.2 Astellas Business Overview
  34. 7.6.3 Astellas Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Astellas Metoclopramide Product Portfolio
  36. 7.6.5 Astellas Recent Developments
  37. 7.7 Biofarma
  38. 7.7.1 Biofarma Company Information
  39. 7.7.2 Biofarma Business Overview
  40. 7.7.3 Biofarma Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Biofarma Metoclopramide Product Portfolio
  42. 7.7.5 Biofarma Recent Developments
  43. 7.8 Ceva Sante Animale
  44. 7.8.1 Ceva Sante Animale Company Information
  45. 7.8.2 Ceva Sante Animale Business Overview
  46. 7.8.3 Ceva Sante Animale Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Ceva Sante Animale Metoclopramide Product Portfolio
  48. 7.8.5 Ceva Sante Animale Recent Developments
  49. 7.9 EU-Pharma
  50. 7.9.1 EU-Pharma Company Information
  51. 7.9.2 EU-Pharma Business Overview
  52. 7.9.3 EU-Pharma Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 EU-Pharma Metoclopramide Product Portfolio
  54. 7.9.5 EU-Pharma Recent Developments
  55. 7.10 Le Vet
  56. 7.10.1 Le Vet Company Information
  57. 7.10.2 Le Vet Business Overview
  58. 7.10.3 Le Vet Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Le Vet Metoclopramide Product Portfolio
  60. 7.10.5 Le Vet Recent Developments
  61. 7.11 Meda Pharma
  62. 7.11.1 Meda Pharma Company Information
  63. 7.11.2 Meda Pharma Business Overview
  64. 7.11.3 Meda Pharma Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Meda Pharma Metoclopramide Product Portfolio
  66. 7.11.5 Meda Pharma Recent Developments
  67. 7.12 Nidda
  68. 7.12.1 Nidda Company Information
  69. 7.12.2 Nidda Business Overview
  70. 7.12.3 Nidda Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Nidda Metoclopramide Product Portfolio
  72. 7.12.5 Nidda Recent Developments
  73. 7.13 Omega Laboratories
  74. 7.13.1 Omega Laboratories Company Information
  75. 7.13.2 Omega Laboratories Business Overview
  76. 7.13.3 Omega Laboratories Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Omega Laboratories Metoclopramide Product Portfolio
  78. 7.13.5 Omega Laboratories Recent Developments
  79. 7.14 Orion Pharma
  80. 7.14.1 Orion Pharma Company Information
  81. 7.14.2 Orion Pharma Business Overview
  82. 7.14.3 Orion Pharma Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Orion Pharma Metoclopramide Product Portfolio
  84. 7.14.5 Orion Pharma Recent Developments
  85. 7.15 Teuto Brasileiro
  86. 7.15.1 Teuto Brasileiro Company Information
  87. 7.15.2 Teuto Brasileiro Business Overview
  88. 7.15.3 Teuto Brasileiro Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Teuto Brasileiro Metoclopramide Product Portfolio
  90. 7.15.5 Teuto Brasileiro Recent Developments
  91. 7.16 Wockhardt
  92. 7.16.1 Wockhardt Company Information
  93. 7.16.2 Wockhardt Business Overview
  94. 7.16.3 Wockhardt Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Wockhardt Metoclopramide Product Portfolio
  96. 7.16.5 Wockhardt Recent Developments
  97. 7.17 Yang Sheng
  98. 7.17.1 Yang Sheng Company Information
  99. 7.17.2 Yang Sheng Business Overview
  100. 7.17.3 Yang Sheng Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Yang Sheng Metoclopramide Product Portfolio
  102. 7.17.5 Yang Sheng Recent Developments
  103. 7.18 GSK
  104. 7.18.1 GSK Company Information
  105. 7.18.2 GSK Business Overview
  106. 7.18.3 GSK Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 GSK Metoclopramide Product Portfolio
  108. 7.18.5 GSK Recent Developments
  109. 7.19 Pfizer
  110. 7.19.1 Pfizer Company Information
  111. 7.19.2 Pfizer Business Overview
  112. 7.19.3 Pfizer Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Pfizer Metoclopramide Product Portfolio
  114. 7.19.5 Pfizer Recent Developments
  115. 7.20 Mylan
  116. 7.20.1 Mylan Company Information
  117. 7.20.2 Mylan Business Overview
  118. 7.20.3 Mylan Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Mylan Metoclopramide Product Portfolio
  120. 7.20.5 Mylan Recent Developments
  121. 7.21 Novartis
  122. 7.21.1 Novartis Company Information
  123. 7.21.2 Novartis Business Overview
  124. 7.21.3 Novartis Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Novartis Metoclopramide Product Portfolio
  126. 7.21.5 Novartis Recent Developments
  127. 7.22 Johnson and Johnson
  128. 7.22.1 Johnson and Johnson Company Information
  129. 7.22.2 Johnson and Johnson Business Overview
  130. 7.22.3 Johnson and Johnson Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Johnson and Johnson Metoclopramide Product Portfolio
  132. 7.22.5 Johnson and Johnson Recent Developments
  133. 7.23 Sanofi
  134. 7.23.1 Sanofi Company Information
  135. 7.23.2 Sanofi Business Overview
  136. 7.23.3 Sanofi Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Sanofi Metoclopramide Product Portfolio
  138. 7.23.5 Sanofi Recent Developments
  139. 7.24 Teva
  140. 7.24.1 Teva Company Information
  141. 7.24.2 Teva Business Overview
  142. 7.24.3 Teva Metoclopramide Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Teva Metoclopramide Product Portfolio
  144. 7.24.5 Teva Recent Developments
8 North America
  1. 8.1 North America Metoclopramide Market Size by Type
  2. 8.1.1 North America Metoclopramide Revenue by Type (2021-2032)
  3. 8.1.2 North America Metoclopramide Sales by Type (2021-2032)
  4. 8.1.3 North America Metoclopramide Price by Type (2021-2032)
  5. 8.2 North America Metoclopramide Market Size by Application
  6. 8.2.1 North America Metoclopramide Revenue by Application (2021-2032)
  7. 8.2.2 North America Metoclopramide Sales by Application (2021-2032)
  8. 8.2.3 North America Metoclopramide Price by Application (2021-2032)
  9. 8.3 North America Metoclopramide Market Size by Country
  10. 8.3.1 North America Metoclopramide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Metoclopramide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Metoclopramide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Metoclopramide Market Size by Type
  2. 9.1.1 Europe Metoclopramide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Metoclopramide Sales by Type (2021-2032)
  4. 9.1.3 Europe Metoclopramide Price by Type (2021-2032)
  5. 9.2 Europe Metoclopramide Market Size by Application
  6. 9.2.1 Europe Metoclopramide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Metoclopramide Sales by Application (2021-2032)
  8. 9.2.3 Europe Metoclopramide Price by Application (2021-2032)
  9. 9.3 Europe Metoclopramide Market Size by Country
  10. 9.3.1 Europe Metoclopramide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Metoclopramide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Metoclopramide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Metoclopramide Market Size by Type
  2. 10.1.1 China Metoclopramide Revenue by Type (2021-2032)
  3. 10.1.2 China Metoclopramide Sales by Type (2021-2032)
  4. 10.1.3 China Metoclopramide Price by Type (2021-2032)
  5. 10.2 China Metoclopramide Market Size by Application
  6. 10.2.1 China Metoclopramide Revenue by Application (2021-2032)
  7. 10.2.2 China Metoclopramide Sales by Application (2021-2032)
  8. 10.2.3 China Metoclopramide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Metoclopramide Market Size by Type
  2. 11.1.1 Asia Metoclopramide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Metoclopramide Sales by Type (2021-2032)
  4. 11.1.3 Asia Metoclopramide Price by Type (2021-2032)
  5. 11.2 Asia Metoclopramide Market Size by Application
  6. 11.2.1 Asia Metoclopramide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Metoclopramide Sales by Application (2021-2032)
  8. 11.2.3 Asia Metoclopramide Price by Application (2021-2032)
  9. 11.3 Asia Metoclopramide Market Size by Country
  10. 11.3.1 Asia Metoclopramide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Metoclopramide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Metoclopramide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Metoclopramide Market Size by Type
  2. 12.1.1 SAMEA Metoclopramide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Metoclopramide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Metoclopramide Price by Type (2021-2032)
  5. 12.2 SAMEA Metoclopramide Market Size by Application
  6. 12.2.1 SAMEA Metoclopramide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Metoclopramide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Metoclopramide Price by Application (2021-2032)
  9. 12.3 SAMEA Metoclopramide Market Size by Country
  10. 12.3.1 SAMEA Metoclopramide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Metoclopramide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Metoclopramide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Metoclopramide Value Chain Analysis
  2. 13.1.1 Metoclopramide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Metoclopramide Production Mode & Process
  6. 13.2 Metoclopramide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Metoclopramide Distributors
  9. 13.2.3 Metoclopramide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst